Email Us

The Disease Susceptibility Genetic Test-Cardiovascular Protection CapitalBio

This test bases on biochip technology, evaluate the risk of three thrombotic diseases from the perspective of genetics, and detect the metabolic enzyme-related polymorphism loci and drug action targets of the three thrombotic drugs, guide the prevention of thrombotic diseases and rationally adjust the dosage of drugs, reduce side effects and improve cure rate. Please feel free to contact us and get more information on personal genetic testing!

the disease susceptibility genetic test cardiovascular protection

Test Content of the Disease Susceptibility Genetic Test-Cardiovascular Protection

Assess the risk of coronary heart disease, stroke, and venous thrombosis (genetic testing of individualized medication for thrombotic diseases: warfarin, clopidogrel, nitroglycerin).

Specification of the Disease Susceptibility Genetic Test-Cardiovascular Protection

Sample typesVenous blood / Oral swab
TAT9 working days


Products
Contact with Capitalbio
Contact Information
Your Inquiries (Expandable)
Instruments
Detection Kits/Reagents
Research Services
Biochip Design & Fabrication
Diagnostic Services
86-10-69002900
Building C, Block 88 Kechuang 6th Street, Yizhuang Biomedical Park, Beijing